Literature DB >> 32507341

Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.

Jacqueline T DesJardin1, Nicholas A Kolaitis2, Noah Kime3, Richard A Kronmal3, Raymond L Benza4, Jean M Elwing5, Matthew R Lammi6, John W McConnell7, Kenneth W Presberg8, Jeffrey S Sager9, Oksana A Shlobin10, Teresa De Marco2.   

Abstract

BACKGROUND: The age of patients with pulmonary arterial hypertension (PAH) has increased, with registries now reporting mean ages of 50 to 65 years old. Limited data exist on age-related differences in hemodynamic and functional assessments in PAH.
METHODS: Adults with PAH in the Pulmonary Hypertension Association Registry were divided into 3 groups (18-50, 51-65, and >65 years old). Analysis of variance and chi-square testing were used to assess for baseline differences. Linear regression was used to examine the association of age with continuous hemodynamic and functional variables.
RESULTS: A total of 769 patients with mean age of 56 ± 16 years were included. Older patients had more connective tissue disease-associated PAH and less drug-associated PAH. In linear regression models, each year of increased age was associated with shorter 6-minute walk distance (-3.37 meters; 95% CI, -3.97 to -2.76), lower mean pulmonary arterial pressure (-0.21 mm Hg; 95% CI, -0.27 to -0.15), and lower pulmonary vascular resistance (-0.06 Wood units; 95% CI, -0.09 to -0.04). Pulmonary arterial compliance, cardiac index, right ventricular stroke work index, and percent predicted 6-minute walk distance were unrelated to age; resistance-compliance time was negatively related to age (-3 milliseconds per year; 95% CI, -4 to -2).
CONCLUSIONS: Relative to their pulmonary vascular resistance, older patients have lower pulmonary artery compliance and worse right ventricular performance. Based on these findings, we suspect that age influences right ventricular loading conditions and the response of the right ventricle to increased afterload. Published by Elsevier Inc.

Entities:  

Keywords:  functional assessments; hemodynamics; pulmonary arterial hypertension; pulmonary artery compliance; pulmonary vascular resistance

Year:  2020        PMID: 32507341     DOI: 10.1016/j.healun.2020.05.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  On errata and corrigenda-The Pulmonary Hypertension Association Registry (PHAR).

Authors:  Kayleen Williams; Noah A Kime; Richard A Kronmal; Nadine Al-Naamani
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

2.  Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.

Authors:  Nicholas A Kolaitis; Roham T Zamanian; Vinicio A de Jesus Perez; David B Badesch; Raymond L Benza; Charles D Burger; Murali M Chakinala; Jean M Elwing; Jeremy Feldman; Matthew R Lammi; Stephen C Mathai; John W McConnell; Kenneth W Presberg; Jeffrey C Robinson; Jeffrey Sager; Oksana A Shlobin; Marc A Simon; Steven M Kawut; David V Glidden; Jonathan P Singer; Teresa De Marco
Journal:  Ann Am Thorac Soc       Date:  2021-04

3.  Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR).

Authors:  Jasleen Minhas; Sai Prasanna Narasimmal; Todd M Bull; Teresa De Marco; John Wesley McConnell; Matthew R Lammi; Thenappan Thenappan; Jeremy P Feldman; Jeffrey S Sager; David B Badesch; John J Ryan; Daniel C Grinnan; Dianne Zwicke; Evelyn M Horn; Jean M Elwing; John E Moss; Michael Eggert; Oksana A Shlobin; Robert P Frantz; Sonja D Bartolome; Stephen C Mathai; Sula Mazimba; Steven C Pugliese; Nadine Al-Naamani
Journal:  Pulm Circ       Date:  2021-10-14       Impact factor: 2.886

4.  Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis.

Authors:  Hui-Ru Zhu; Hong-Yu Kuang; Qiang Li; Xiao-Juan Ji
Journal:  Front Cardiovasc Med       Date:  2022-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.